For the quarter ending 2025-09-30, SBFM made $9,417,179 in revenue. -$1,485,448 in net income. Net profit margin of -15.77%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 9,417,179 | 9,410,230 | 8,901,341 | 8,568,019 |
| Cost of sales | 6,343,639 | 5,987,364 | 6,170,915 | 5,844,326 |
| Gross profit | 3,073,540 | 3,422,866 | 2,730,426 | 2,723,693 |
| Accounting | 135,413 | 75,611 | 293,759 | 377,224 |
| Consulting | 159,003 | 736,727 | 365,287 | 150,052 |
| Director fees | 100,000 | 100,000 | 100,000 | 100,000 |
| Legal | 193,009 | 64,995 | 27,199 | 266,975.5 |
| Marketing | 235,217 | 201,658 | 398,361 | 200,604 |
| Office | 614,661 | 806,605 | 925,878 | 859,897.333 |
| R&d | 119,298 | 196,232 | 215,277 | 185,652.5 |
| Salaries | 1,833,172 | 2,048,676 | 1,525,446 | 2,034,325.5 |
| Taxes | 119,909 | 112,675 | 110,176 | - |
| Depreciation & amortization | - | - | - | 55,881.75 |
| Impairment of intangible assets | 554,650 | 1,061,809 | - | - |
| Taxes | - | - | - | 80,400 |
| Depreciation | 95,821 | 72,533 | 64,793 | - |
| Total g & a | 4,160,153 | 5,477,521 | 4,026,176 | 4,442,439 |
| (loss) from operations | -1,086,613 | -2,054,655 | -1,295,750 | -1,718,746 |
| (loss) on asset sale | -10,250 | - | - | - |
| Foreign exchange gain (loss) | 253 | 1,940 | 451 | -172,885 |
| Interest income | 75,352 | 72,715 | 75,367 | 121,697 |
| Interest expense | 0 | 0 | - | 2,843 |
| Total other income (expenses) | 65,355 | 74,655 | 75,818 | -55,452.5 |
| Net (loss) before income taxes | -1,021,258 | -1,980,000 | -1,219,932 | -1,774,198.5 |
| Provision for income taxes | -137,438 | -209,166 | -40,161 | -53,192 |
| Net (loss) | -883,820 | -1,770,834 | -1,179,771 | -1,721,006.5 |
| Gain (loss) from foreign exchange translation | -601,628 | 1,084,557 | - | -771,127 |
| Comprehensive (loss) | -1,485,448 | -686,277 | - | -2,492,133.5 |
| Earnings per share, diluted | - | -0.82 | -0.44 | -1.83 |
| Weighted average number of shares outstanding, diluted | - | 3,604,653 | 2,703,293 | -307,771 |
| Basic (loss) per common share | -0.19 | -0.39 | -0.44 | 1.78 |
| Weighted average common shares outstanding (basic) | 4,555,945 | 4,496,108 | 2,703,293 | -307,771 |
Sunshine Biopharma Inc. (SBFM)
Sunshine Biopharma Inc. (SBFM)